Investor mix
5 investors on record; lead investors include Genextra, Sofinnova Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |
Developer of an erythrocyte encapsulation drug delivery system
5 investors on record; lead investors include Genextra, Sofinnova Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |